Biotx.ai
Biotx.ai delivers predictive biomarkers as a basis for decision support in precision medicine. They use novel, state of the art, machine learning approaches specifically designed to find complex patterns in biomedical data.
Focus: Genomics-focused drug discovery platform
Team: Joern Klinger (CEO) and Marco Schmidt (CSO)
Website: https://biotx.ai/
See other Genomics organisations
-
Genevation LTD is a Cancer therapeutics company. We will develop and manufacture personalized cancer vaccines. We are one of the ... -
Svastia offers clinical decision support for cancer treatment selection and relapse prediction. -
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting clonal neoantigens: protein markers unique to the individual ... -
Aglaris Ltd produce equipment to ensure cell and tissue culture is an easy, problem-free task.
Be part of SBC Catalyser Programme!
Spaces are limited to a maximum of 10 companies per cohort. Contact Marco to know more or to apply.
Contact MarcoCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.